Policy | October 12, 2025
AstraZeneca to lower cost of medicines for American patients
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Accelerating sustainability in Indian pharma industry
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Subscribe To Our Newsletter & Stay Updated
